Hsin-Wei Chen Selected Research

Hsin-Wei Chen Research Topics

Disease

22	Neoplasms (Cancer) 07/2021 - 08/2002
11	Infections 08/2022 - 07/2007
10	Dengue (Dengue Fever) 01/2020 - 02/2009
5	COVID-19 06/2022 - 01/2021
4	Virus Diseases (Viral Diseases) 04/2022 - 02/2009
4	Viremia 01/2020 - 03/2014
3	Inflammation (Inflammations) 10/2021 - 08/2015
3	Communicable Diseases (Infectious Diseases) 01/2019 - 08/2010
3	Human Influenza (Influenza) 08/2010 - 05/2009
2	Insulin Resistance 10/2021 - 09/2019
2	Adenocarcinoma 11/2019 - 08/2016
2	Melanoma (Melanoma, Malignant) 01/2019 - 01/2011
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2014 - 01/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 03/2003 - 08/2002
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 06/2022
1	Vesicular Stomatitis 01/2022
1	Fatty Liver 10/2021
1	Obesity 10/2021
1	Glucose Intolerance 10/2021
1	Zika Virus Infection 01/2021
1	Mosquito-Borne Diseases 01/2020
1	Measles 01/2020
1	Carcinogenesis 08/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Diarrhea 08/2015
1	Cross Infection (Nosocomial Infection) 08/2015
1	Clostridium Infections 08/2015

Drug/Important Bio-Agent (IBA)

17	VaccinesIBA 06/2022 - 03/2003
13	AntigensIBA 04/2022 - 08/2010
8	Proteins (Proteins, Gene)FDA Link 08/2022 - 08/2002
6	LipidsIBA 10/2021 - 03/2014
6	Peptides (Polypeptides)IBA 01/2016 - 07/2007
4	CytokinesIBA 01/2020 - 03/2003
4	Toll-Like Receptor 2IBA 05/2016 - 03/2014
4	Neutralizing AntibodiesIBA 02/2016 - 07/2013
4	Subunit VaccinesIBA 01/2015 - 01/2011
4	Interleukin-6 (Interleukin 6)IBA 09/2011 - 01/2005
3	Dengue VaccinesIBA 01/2020 - 02/2009
3	InterleukinsIBA 01/2019 - 04/2011
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2018 - 08/2002
3	Lipoproteins (Lipoprotein)IBA 03/2016 - 03/2014
3	Combined VaccinesIBA 01/2016 - 02/2009
2	A-Form DNA (A-DNA)IBA 06/2022 - 06/2022
2	Therapeutic UsesIBA 06/2022 - 05/2006
2	Immune Sera (Antisera)IBA 04/2022 - 03/2003
2	AntibodiesIBA 01/2022 - 01/2011
2	SurvivinIBA 07/2021 - 01/2018
2	Prorenin ReceptorIBA 11/2019 - 08/2016
2	aluminum sulfate (alum)IBA 02/2016 - 02/2014
2	CPG-oligonucleotideIBA 01/2016 - 03/2014
2	EpitopesIBA 01/2016 - 04/2012
2	CD40 Ligand (CD40L)IBA 03/2003 - 08/2002
1	Monoclonal AntibodiesIBA 06/2022
1	DNA VaccinesIBA 06/2022
1	FurinIBA 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	CarbohydratesIBA 10/2021
1	phthalic acid (phthalate)IBA 10/2021
1	Pregnane X ReceptorIBA 10/2021
1	Alanine Transaminase (SGPT)IBA 10/2021
1	CholesterolIBA 10/2021
1	Diethylhexyl Phthalate (DEHP)IBA 10/2021
1	LDL CholesterolIBA 10/2021
1	LeptinIBA 10/2021
1	SqualeneIBA 09/2021
1	Protein Subunits (Protein Subunit)IBA 09/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 08/2020
1	mono-(2-ethylhexyl)phthalateIBA 08/2020
1	Protons (Proton)IBA 08/2020
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2020
1	Peptide Hormones (Polypeptide Hormones)IBA 09/2019
1	Glucose (Dextrose)FDA LinkGeneric 09/2019
1	fibroblast growth factor 21IBA 09/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Interleukin-17 ReceptorsIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	InterferonsIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	Programmed Cell Death 1 ReceptorIBA 03/2016
1	Gemcitabine FDA Link 03/2016
1	Pharmaceutical PreparationsIBA 03/2016
1	Monatide (IMS 3015)IBA 01/2016
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 08/2015
1	ExotoxinsIBA 08/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2015
1	trimethylaminocarboxyldihydroboran (TCDB)IBA 08/2015
1	EndotoxinsIBA 01/2015
1	Recombinant ProteinsIBA 01/2015
1	OligodeoxyribonucleotidesIBA 03/2014
1	Toll-Like Receptor AgonistsIBA 03/2014

Therapy/Procedure

9	Immunotherapy 01/2019 - 03/2003
8	Therapeutics 07/2021 - 03/2003
2	Drug Therapy (Chemotherapy) 07/2021 - 03/2016
1	Intramuscular Injections 06/2022
1	Electroacupuncture 06/2022
1	Immunomodulation 09/2021
1	Intranasal Administration 01/2021